.avif)
Granza Bio is developing “attack particles” — autonomous killing entities released from cytotoxic immune cells — to reprogram immunity for target-specific medicines. This discovery, originating from co-founder Prof. Dustin's lab at the University of Oxford, aims to transform the fight against cancers, autoimmune diseases, and infections. The company is focused on harnessing this novel immune mechanism for therapeutic applications.
.svg)
